{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "4059475",
  "DateCompleted": {
    "Year": "1985",
    "Month": "12",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0306-4530",
      "JournalIssue": {
        "Volume": "10",
        "Issue": "3",
        "PubDate": {
          "Year": "1985"
        }
      },
      "Title": "Psychoneuroendocrinology",
      "ISOAbbreviation": "Psychoneuroendocrinology"
    },
    "ArticleTitle": "Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.",
    "Pagination": {
      "StartPage": "281",
      "EndPage": "288",
      "MedlinePgn": "281-8"
    },
    "Abstract": {
      "AbstractText": [
        "Failure to suppress cortisol secretion after administration of dexamethasone has been reported to be a diagnostic marker for major depression and to have prognostic implications when repeated after antidepressant treatment. The pulsatile pattern of cortisol secretion suggested to us that increasing the number of post-dexamethasone cortisol determinations might significantly increase the sensitivity of the dexamethasone suppression test (DST) for major depression. With a conventional two-point DST (1600 h and midnight), 5% of 20 normal volunteers, 8% of 13 inpatients with non-major depressions, and 31% of 65 inpatients with primary major depression failed to suppress. With six post-dexamethasone points (0800 h, 1200 h, 1600 h, 2000 h, 2200 h, midnight), the respective percentages were 10, 15 and 44%. The additional points increased the sensitivity from 31 to 44%, mostly by identifying more major depressives with a \"late escape\" pattern. If a clinician is using the DST to establish a marker for major depression that can be repeated to monitor response to treatment and the likelihood of relapse, then perhaps the increased sensitivity of the six-point DST would be helpful, despite a modest decrease in specificity from 94 to 88%."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Extein",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pottash",
        "ForeName": "A L",
        "Initials": "AL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gold",
        "ForeName": "M S",
        "Initials": "MS"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Psychoneuroendocrinology",
    "NlmUniqueID": "7612148",
    "ISSNLinking": "0306-4530"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "7S5I7G3JQL",
      "NameOfSubstance": "Dexamethasone"
    },
    {
      "RegistryNumber": "WI4X0X7BPJ",
      "NameOfSubstance": "Hydrocortisone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Adjustment Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Bipolar Disorder"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dexamethasone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Hydrocortisone"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Hypothalamo-Hypophyseal System"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Pituitary-Adrenal System"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ]
}